7-Amino-4-methylcoumarin-3-acetic Acid>95.0%(HPLC)(T)250mg

PYRIDIN-3-YL TRIFLUOROMETHANESULFONATE, 95.0%, 250mg

Fmoc-Thr(Trt)-OH, 95%, 1g

(3aR,5R,6S,6aR)-5-(((tert-Butyldiphenylsilyl)oxy)methyl)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-6-ol, 95%, 5g

(4-Methyl-2-nitrophenyl)boronic acid, 95.0%, 5g

Cyclopropyl 3-(3-pyrrolinomethyl)phenyl ketone, 97.0%, 1g

(4-Chloro-2-ethylphenyl)amine, 95.0%, 25g

Bis(N,N,N'N'-tetramethyl-L-tartramideglycolato)diboron, 5g

(2E)-1-(3-chlorophenyl)-3-(2-fluorophenyl)prop-2-en-1-one, 95.0%, 10g

(1-(Oxetan-3-yl)-1H-pyrazol-5-yl)boronic acid pinacol ester, 95.0%, 100mg

(S)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)-4,4-difluoropiperidine-2-carboxylic acid, 97%, 250mg

Ethyl imidazole-2-carboxylate, 95.0%, 10g

Colonna capillare per GC ROTI®Cap-5, 60 m, 0.32 mm, 3.00 µm, 1 Pezzo(i)